Carlsmed, Inc. (CARL) Tops Q4 EPS by 3c

Carlsmed, Inc. (NASDAQ: CARL) reported Q4 EPS of ($0.32), $0.03 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $14.9 million.

For earnings history and earnings-related data on Carlsmed, Inc. (CARL) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Lockheed Martin wins $153 million in defense contracts
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance